J
Jae-Hyun Park
Researcher at University of Chicago
Publications - 94
Citations - 4053
Jae-Hyun Park is an academic researcher from University of Chicago. The author has contributed to research in topics: Cancer & T cell. The author has an hindex of 34, co-authored 93 publications receiving 3459 citations. Previous affiliations of Jae-Hyun Park include University of Tokyo & Seoul National University.
Papers
More filters
Journal ArticleDOI
Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
Elizabeth S. Nakasone,Hanne A. Askautrud,Tim Kees,Jae-Hyun Park,Vicki Plaks,Andrew J. Ewald,Andrew J. Ewald,Miriam R. Fein,Miriam R. Fein,Morten Grønbech Rasch,Morten Grønbech Rasch,Ying Xim Tan,Jing Qiu,Juwon Park,Pranay Sinha,Mina J. Bissell,Eirik Frengen,Eirik Frengen,Zena Werb,Mikala Egeblad,Mikala Egeblad +20 more
TL;DR: Live imaging of chemotherapy-treated mouse mammary carcinomas allowed us to follow drug distribution, cell death, and tumor-stroma interactions, and associations between vascular leakage and response to doxorubicin, showing that the microenvironment contributes critically to drug response via regulation of vascular permeability and innate immune cell infiltration.
Journal ArticleDOI
Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligonucleotide Microarrays
Hio Chung Kang,Il-Jin Kim,Jae-Hyun Park,Yong Shin,Ja-Lok Ku,Mi Sun Jung,Byong Chul Yoo,Hark Kyun Kim,Jae-Gahb Park +8 more
TL;DR: Midkine (MDK), a heparin-binding growth factor, was overexpressed in all drug-resistant cell lines, strongly suggesting that MDK might contribute to multidrug resistance in gastric cancer cells.
Journal ArticleDOI
PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast Cancer
TL;DR: It is suggested that PBK/TOPK is the cancer/testis antigen and its kinase function is likely to be related to its oncogenic activity, and it is suggested to be a promising molecular target for breast cancer therapy.
Journal ArticleDOI
Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.
TL;DR: The findings suggest that the kinase activity of MELK is likely to affect mammary carcinogenesis through inhibition of the pro-apoptotic function of Bcl-GL.
Journal ArticleDOI
Myasthenic crisis and polymyositis induced by one dose of nivolumab
Toshihiro Kimura,Satoshi Fukushima,Azusa Miyashita,Jun Aoi,Masatoshi Jinnin,Takayuki Kosaka,Yukio Ando,Masakazu Matsukawa,Hiroyuki Inoue,Kazuma Kiyotani,Jae-Hyun Park,Yusuke Nakamura,Hironobu Ihn +12 more
TL;DR: T cell receptor repertoire analysis using next‐generation sequencing technologies and identified infiltration of clonally expanded T cell populations in the skeletal muscle after nivolumab treatment, implying a very strong T cell immune response against muscular cells.